Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Some birth control pills have a higher risk of blood clots than others.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Higher iron levels in the blood are not linked to increased hair loss in women.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.